Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: THE EMMES COMPANY, LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-08-09 to 2023-08-08
Current total value of award: $9353.97
Description: CLINICAL SITE MONITORING IN HUMAN SUBJECTS FOR AN FOR AN EXTRAMURAL STUDY TO EVALUATE THE ABILITY OF DERMAL OPEN FLOW MICROPERFUSION (DOFM) FOR BIOEQUIVALENCE (BE) TESTING OF DIFFERENT DICLOFENAC PRODUCTS AT JOANNEUM RESEARCH, GRAZ, AUSTRIA. THIS STU